Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2775 SEK | -0.18% | -9.17% | -97.22% |
22/05 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
16/05 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |